Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immuno-thermal ablations - boosting the anticancer immune response.

Ryan Slovak1,2, Johannes M Ludwig1,3, Scott N Gettinger4,5

  • 1Division of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, 330 Cedar Street, New Haven, CT, 06510, USA.

Journal for Immunotherapy of Cancer
|October 18, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated Pretreatment Thoracic CT-Based Body Composition Analysis Predicts Progression-Free Survival in Head and Neck Cancer.

Journal of clinical medicine·2026
Same author

Systemic inflammation plays a key prognostic role in patients with head and neck cancer treated with immunotherapy and is linked to CT-based body composition metrics.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
Same author

Muscle matters: automated CT-based body composition analysis predicts survival in patients with head and neck cancer treated with immunotherapy.

Frontiers in oncology·2026
Same author

Muscle and fat matter: Automated CT-based body composition analysis predicts survival in <i>Hepatocellular carcinoma</i> patients undergoing radioembolization.

European journal of radiology open·2026
Same author

Evaluation of diffusion-weighted imaging datasets for the assessment of disease activity in lymphoma patients.

European journal of radiology·2025
Same author

Retrospective Clinical Studies in Interventional Oncology: Relevance and Challenges.

Cardiovascular and interventional radiology·2025

Combining thermal ablation with immunomodulation shows promise for enhancing anticancer immune responses. This approach amplifies the body's natural defenses to combat tumors more effectively, particularly when using checkpoint inhibitors.

Area of Science:

  • Oncology
  • Immunology
  • Medical Technology

Background:

  • Immunomodulation is gaining traction for cancer treatment.
  • Locoregional thermal ablation can induce anticancer immune effects.
  • Ablation monotherapy often fails to generate a strong antitumor response.

Purpose of the Study:

  • To review animal model studies on combining thermal ablation with immunomodulation.
  • To investigate the immune effects of this combination therapy.
  • To highlight the role of checkpoint blockade in this context.

Main Methods:

  • Review of studies using radiofrequency ablation, cryoablation, and microwave ablation in animal models.
  • Analysis of research combining ablative techniques with immunomodulatory drugs.
Keywords:
Checkpoint inhibitionCombination TherapyCryoablationMicrowave ablationRadiofrequency ablation

Related Experiment Videos

  • Focus on studies incorporating checkpoint inhibitors.

    • Main Results:

    • Combination therapy amplifies immune responses compared to ablation alone.
    • Immunomodulation enhances the systemic anticancer effects of thermal ablation.
    • Checkpoint blockade shows particular promise in combination strategies.

    Conclusions:

    • Combining thermal ablation with immunomodulation is a promising strategy to enhance systemic antitumor immunity.
    • Further research in animal models supports the development of these combination therapies.
    • Checkpoint inhibitors are a key component in optimizing this combined therapeutic approach.